EM, A., PL, d. S. J., SM, S., MH, B., SA, B., & AM, C. (2019). Corrigendum to "Pro-apoptotic effects of Amblyomin-X in murine renal cell carcinoma "in vitro" [Biomed. Pharmacother. 66 (2012) 64-69]. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie, 118, 109108. https://doi.org/10.1016/j.biopha.2019.109108
Chicago Style (17th ed.) CitationEM, Akagi, de Sá Júnior PL, Simons SM, Bellini MH, Barreto SA, and Chudzinski-Tavassi AM. "Corrigendum to "Pro-apoptotic Effects of Amblyomin-X in Murine Renal Cell Carcinoma "in Vitro" [Biomed. Pharmacother. 66 (2012) 64-69]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie 118 (2019): 109108. https://doi.org/10.1016/j.biopha.2019.109108.
MLA (9th ed.) CitationEM, Akagi, et al. "Corrigendum to "Pro-apoptotic Effects of Amblyomin-X in Murine Renal Cell Carcinoma "in Vitro" [Biomed. Pharmacother. 66 (2012) 64-69]." Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie, vol. 118, 2019, p. 109108, https://doi.org/10.1016/j.biopha.2019.109108.